Impact of late treatment-related radiotherapy toxicity, depression, and anxiety on quality of life in long-term breast cancer survivors
INTRODUCTION: This study aimed to assess the impact of late treatment toxicity (especially radiotherapy toxicity), chemoradiotherapy treatment type (concurrent or sequential), depression and anxiety on overall, physical and emotional quality of life (QoL) in long-term breast cancer survivors. Method. We assessed 117 patients (mean follow-up since the end of treatment = 8.1 years) for late radiotherapy toxicity (LENT-SOMA scale), patient and doctor ratings of breast cosmetic outcomes, QoL (EORTC QLQ-C30), depression and anxiety (Hospital and Anxiety Depression scale).
RESULTS: In univariate analyses, factors associated with significantly decreased QoL were: use of sequential treatment and decreased overall QoL (P = 0.002) and emotional QoL (P = 0.02) ; few radiotherapy late toxicity symptoms (pain and decreased physical QoL, P = 0.01 ; fibrosis and decreased emotional QoL, P = 0.04) ; probable depression or probable anxiety and decreased overall, physical and emotional QoL (P ≤ 0.005). In multivariate analyses, probable depression and probable anxiety were the most stronger predictors for decreased QoL in the overall, physical and emotional domains (P ≤ 0.02).
CONCLUSION: Improving screening for and treatment of depression and anxiety might improve QoL in long-term breast cancer survivors.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2012 |
---|---|
Erschienen: |
2012 |
Enthalten in: |
Zur Gesamtaufnahme - volume:99 |
---|---|
Enthalten in: |
Bulletin du cancer - 99(2012), 5 vom: 15. Mai, Seite 589-98 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Impact des complications tardives de la radiothérapie, de la dépression et de l'anxiété sur la qualité de vie à long terme dans le cancer du sein |
---|
Beteiligte Personen: |
Brunault, Paul [VerfasserIn] |
---|
Links: |
---|
Themen: |
Clinical Trial, Phase III |
---|
Anmerkungen: |
Date Completed 11.07.2012 Date Revised 21.03.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1684/bdc.2012.1569 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM21727630X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM21727630X | ||
003 | DE-627 | ||
005 | 20231224033709.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2012 xx |||||o 00| ||fre c | ||
024 | 7 | |a 10.1684/bdc.2012.1569 |2 doi | |
028 | 5 | 2 | |a pubmed24n0724.xml |
035 | |a (DE-627)NLM21727630X | ||
035 | |a (NLM)22531858 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Brunault, Paul |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of late treatment-related radiotherapy toxicity, depression, and anxiety on quality of life in long-term breast cancer survivors |
246 | 3 | 3 | |a Impact des complications tardives de la radiothérapie, de la dépression et de l'anxiété sur la qualité de vie à long terme dans le cancer du sein |
264 | 1 | |c 2012 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.07.2012 | ||
500 | |a Date Revised 21.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: This study aimed to assess the impact of late treatment toxicity (especially radiotherapy toxicity), chemoradiotherapy treatment type (concurrent or sequential), depression and anxiety on overall, physical and emotional quality of life (QoL) in long-term breast cancer survivors. Method. We assessed 117 patients (mean follow-up since the end of treatment = 8.1 years) for late radiotherapy toxicity (LENT-SOMA scale), patient and doctor ratings of breast cosmetic outcomes, QoL (EORTC QLQ-C30), depression and anxiety (Hospital and Anxiety Depression scale) | ||
520 | |a RESULTS: In univariate analyses, factors associated with significantly decreased QoL were: use of sequential treatment and decreased overall QoL (P = 0.002) and emotional QoL (P = 0.02) ; few radiotherapy late toxicity symptoms (pain and decreased physical QoL, P = 0.01 ; fibrosis and decreased emotional QoL, P = 0.04) ; probable depression or probable anxiety and decreased overall, physical and emotional QoL (P ≤ 0.005). In multivariate analyses, probable depression and probable anxiety were the most stronger predictors for decreased QoL in the overall, physical and emotional domains (P ≤ 0.02) | ||
520 | |a CONCLUSION: Improving screening for and treatment of depression and anxiety might improve QoL in long-term breast cancer survivors | ||
650 | 4 | |a Clinical Trial, Phase III | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Multicenter Study | |
700 | 1 | |a Toledano, Alain |e verfasserin |4 aut | |
700 | 1 | |a Aguerre, Colette |e verfasserin |4 aut | |
700 | 1 | |a Suzanne, Isabelle |e verfasserin |4 aut | |
700 | 1 | |a Garaud, Pascal |e verfasserin |4 aut | |
700 | 1 | |a Trzepidur-Edom, Magdalena |e verfasserin |4 aut | |
700 | 1 | |a Calais, Gilles |e verfasserin |4 aut | |
700 | 1 | |a Camus, Vincent |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Bulletin du cancer |d 1966 |g 99(2012), 5 vom: 15. Mai, Seite 589-98 |w (DE-627)NLM000155853 |x 1769-6917 |7 nnns |
773 | 1 | 8 | |g volume:99 |g year:2012 |g number:5 |g day:15 |g month:05 |g pages:589-98 |
856 | 4 | 0 | |u http://dx.doi.org/10.1684/bdc.2012.1569 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 99 |j 2012 |e 5 |b 15 |c 05 |h 589-98 |